Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.04 per share
-
Shares outstanding
-
106,324,269
-
Total 13F shares
-
40,456,202
-
Share change
-
-862,261
-
Total reported value
-
$82,379,793
-
Put/Call ratio
-
0%
-
Price per share
-
$2.04
-
Number of holders
-
61
-
Value change
-
-$1,567,787
-
Number of buys
-
20
-
Number of sells
-
27
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) as of Q2 2025
As of 30 Jun 2025,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,456,202 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., Privium Fund Management B.V., Affinity Asset Advisors, LLC, MORGAN STANLEY, Sio Capital Management, LLC, Aberdeen Group plc, Kynam Capital Management, LP, DAFNA Capital Management LLC, Siren, L.L.C., and Woodline Partners LP.
This page lists
61
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.